首页> 外文OA文献 >Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model
【2h】

Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model

机译:过敏反应模型中重组分枝杆菌作为T辅助1型疫苗的分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The potential for development of mycobacteria as T helper type 1 (Th1) vaccines capable of induction of Th1 responses to recombinant antigens was explored in a model system based on an immunodominant peptide from house dust mite. Different recombinant mycobacterial preparations were compared for their ability to induce a Th1 response to the peptidea. It was found that mycobacterial viability was not a prerequisite for Th1 immunogenicity. A dominant interferon-γ (IFN-γ) response to peptide was observed in splenocytes from C57BL/6J mice immunized with live or heat-killed preparations of recombinant Mycobacterium vaccae or with live attenuated bacillus Calmette–Guèrin (BCG) vaccine expressing the antigen. Interleukin-5 (IL-5), a marker of a Th2 response, was detected only in mice receiving live M. vaccae. A similar pattern was observed in BALB/b mice, although the magnitude of the IFN-γ response was much lower. Control and immunized mice were subsequently exposed to allergen using a Th2-inducing challenge protocol. A significant shift from a Th2 to a Th1 response was observed in immunized mice, as judged by cytokine expression by splenocytes and by subclass of circulating antibody. The effect was seen in three inbred mouse strains differing in their innate bias towards Th1 or Th2 responses. It was dependent on the presence of specific antigen in the mycobacterial preparation and, under the immunization conditions tested, was more pronounced with dead M. vaccae than with live BCG as carrier vaccine. The results demonstrate the potency of killed mycobacteria as Th1 adjuvants and suggest a potential application for recombinant mycobacteria in antigen-specific immune modulation.
机译:在基于来自屋尘螨的免疫优势肽的模型系统中,探索了分枝杆菌作为能够诱导Th1对重组抗原应答的T型辅助1(Th1)疫苗的潜力。比较了不同的重组分枝杆菌制剂诱导Th1对肽反应的能力。发现分枝杆菌的生存力不是Th1免疫原性的前提。在用活的或热灭活的重组牛分枝杆菌制剂或表达抗原的减毒活卡介苗(BCG)疫苗免疫的C57BL / 6J小鼠的脾细胞中,观察到对肽的显性干扰素-γ(IFN-γ)反应。仅在接受活牛痘菌的小鼠中检测到Th2反应的标志物白细胞介素5(IL-5)。在BALB / b小鼠中观察到了类似的模式,尽管IFN-γ反应的幅度要低得多。随后使用诱导Th2的攻击方案将对照和免疫的小鼠暴露于变应原。通过脾细胞和循环抗体亚类的细胞因子表达判断,在免疫小鼠中观察到了从Th2反应到Th1反应的明显转变。在三种自交系小鼠对Th1或Th2反应的先天偏见方面有所不同。它取决于分枝杆菌制剂中特定抗原的存在,并且在测试的免疫条件下,死的牛痘分枝杆菌比活的BCG作为载体疫苗更明显。结果证明了杀死的分枝杆菌作为Th1佐剂的效力,并暗示了重组分枝杆菌在抗原特异性免疫调节中的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号